The 14th Neuro-Oncology Brain Tumor Symposium will take place on February 5, 2027, at the Rubenstein Auditorium, Smilow Center for Translational Research, in Philadelphia, Pennsylvania, United States, with virtual participation also available.

Organized by Penn Medicine, the symposium will bring together clinicians, researchers, patients, and caregivers to discuss advances in brain tumor diagnosis, treatment, and supportive care.

The educational program will explore developments in precision neuro-oncology, including next-generation sequencing, molecular profiling, advanced neuroimaging, immunotherapy, CAR-T cell therapy, and emerging treatment strategies for gliomas and brain metastases. Additional discussions will address the clinical implications of the INDIGO trial and vorasidenib for IDH-mutant gliomas, alongside innovations in surgical imaging, radiation therapy, and liquid biopsy.

Designed for multidisciplinary healthcare professionals as well as patients and their families, the symposium will combine scientific updates with practical approaches to treatment decisions, symptom management, and quality of life. Participants will have opportunities to engage with specialists and learn about developments shaping contemporary brain tumor